Global Antivenom Market Size, Share, Trends, and Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

31/mag/2018 14:39:55 SAI Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Antivenom Market Size, Share, Trends, and Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

Global Antivenom Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024

 

Antivenom is also called as antivenin. Antivenom is a medication prepared from antibodies which are used to treat certain venomous bites. Poisonous bites result in certain clinical conditions such as muscle weakness, secretion of excessive saliva, breathing problems, along with other difficulties, in some instance that might lead to death as well. Antivenins are recommended only if there is significant toxicity or high risk of toxicity. Antivenom is made by collecting venom from the relevant venomous species of spider, snake, fish, injecting venom in little amounts to domestic animals and antibodies are separated from blood purification. These antibodies are used as antivenom.

 

Increase in government initiatives to develop antivenoms and incidents of the venomous bites in undeveloped regions are fuelling the growth of antivenom market over the forecast period. In addition, rise in deaths due to venomous bites and technological advancements in the development of antivenom creates significant opportunities for the antivenom manufacturers. However, complexity in regulatory procedures, insufficient funding in development of antivenom, and high cost of the product are hindering growth of antivenom market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-antivenom-market/#ulp-4H8Z4LpNMLEuOnnx

 

Antivenom market segmented based on product type, animal, and distribution channel

 

Based on product type, global antivenom market has been segmented into

·        Monovalent

·        Polyvalent

On the basis of animal, global antivenom market is segmented into

·        Snake

·        Scorpions

·        Spiders

·        Others

On the basis of distribution channel, global antivenom market is segmented into

·        Hospital Pharmacies

·        Retail Pharmacies

·        Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-antivenom-market/#ulp-4H8Z4LpNMLEuOnnx

 

Growing demand of antivenom worldwide, especially in Africa and Asia-Pacific region owing to more number of venomous bite incidents. According to World Health Organization (WHO), about 5 Mn snake bites occur each year, resulting 2.5 Mn envenomings (poisoning because of snake bites), minimum 100,000 deaths and around three times as many amputations and other permanent disabilities. Withdrawal of antivenoms like Fav-Afrique by Pfizer further grew demand for the market. Market players are also actively involving in R&D to develop antivenoms and to enhance their market position. In addition, many market players and institutions are actively involved in the development of new antivenoms. For instance, Equine F (ab’) 2 in antivenin is being developed by Instituto Bioclon S.A (clinical trials phase 2) for treatment of poisoning by scorpion sting. Based on the aforementioned factors antivenom market is expected to grow with significant CAGR rate during the forecast period.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-antivenom-market/#ulp-14mlyhjMGhVjZqa3

 

 

Some of the players in Antivenom Market are Vins Bioproducts Limited (India), Bharat Serum and Vaccines Limited (India), CSL Limited (Victoria), Rare Disease Therapeutics, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland),  Instituto Bioclon, S.A. de C.V.(Mexico), Incepta Vaccine Ltd. (Bangladesh), BTG Plc (U.K), Merck & Co., Inc. (U.S), and Pfizer Inc. (U.S.), to name a few.

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

Landon EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl